A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma.

MLA

Demir, Emre, et al. “A Possible Interaction between Favipiravir and Methotrexate: Drug-Induced Hepatotoxicity in a Patient with Osteosarcoma.” Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, vol. 28, no. 2, Mar. 2022, pp. 445–48. EBSCOhost, https://doi.org/10.1177/10781552211031304.

APA

Demir, E., Sütcüoğlu, O., Demir, B., Ünsal, O., & Yazıcı, O. (2022). A possible interaction between favipiravir and methotrexate: Drug-induced hepatotoxicity in a patient with osteosarcoma. Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners, 28(2), 445–448. https://doi.org/10.1177/10781552211031304

Chicago

Demir, Emre, Osman Sütcüoğlu, Beril Demir, Oktay Ünsal, and Ozan Yazıcı. 2022. “A Possible Interaction between Favipiravir and Methotrexate: Drug-Induced Hepatotoxicity in a Patient with Osteosarcoma.” Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners 28 (2): 445–48. doi:10.1177/10781552211031304.